Alignment Healthcare (NASDAQ:ALHC – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.14) earnings per share for the quarter, meeting the consensus estimate of ($0.14), Briefing.com reports. The company had revenue of $692.43 million during the quarter, compared to analysts’ expectations of $662.11 million. Alignment Healthcare had a negative return on equity of 101.10% and a negative net margin of 6.85%. The firm’s quarterly revenue was up 51.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.19) earnings per share. Alignment Healthcare updated its FY 2024 guidance to EPS and its Q4 2024 guidance to EPS.
Alignment Healthcare Stock Performance
Shares of ALHC traded up $0.06 on Wednesday, reaching $11.77. The company’s stock had a trading volume of 458,045 shares, compared to its average volume of 1,010,891. The company has a debt-to-equity ratio of 1.70, a current ratio of 1.61 and a quick ratio of 1.61. The stock has a market capitalization of $2.25 billion, a P/E ratio of -13.76 and a beta of 1.47. The stock’s 50 day simple moving average is $10.62 and its two-hundred day simple moving average is $8.69. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $12.36.
Insider Buying and Selling
In related news, insider Dawn Christine Maroney sold 7,074 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $9.02, for a total value of $63,807.48. Following the transaction, the insider now owns 1,789,023 shares of the company’s stock, valued at approximately $16,136,987.46. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, insider Dawn Christine Maroney sold 7,074 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $9.02, for a total value of $63,807.48. Following the sale, the insider now owns 1,789,023 shares in the company, valued at approximately $16,136,987.46. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Robert Thomas Freeman sold 8,561 shares of the business’s stock in a transaction on Wednesday, September 11th. The shares were sold at an average price of $10.01, for a total transaction of $85,695.61. Following the transaction, the chief financial officer now owns 399,429 shares in the company, valued at $3,998,284.29. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 314,940 shares of company stock valued at $3,487,014. 6.60% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on ALHC
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Articles
- Five stocks we like better than Alignment Healthcare
- Insider Trades May Not Tell You What You Think
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- P/E Ratio Calculation: How to Assess Stocks
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Quiet Period Expirations Explained
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.